Last updated: 15 June 2023 at 6:18pm EST

Dr. Lindsey Rolfe B.Sc., BSc, MB ChB, MRCP, FFPM Net Worth




The estimated Net Worth of Lindsey Rolfe is at least 782 千$ dollars as of 1 November 2022. Dr Rolfe owns over 8,374 units of Clovis Oncology Inc stock worth over 9,284$ and over the last 9 years he sold CLVS stock worth over 0$. In addition, he makes 773,078$ as Exec. VP of Clinical Devel. & Pharmacovigilance and Chief Medical Officer at Clovis Oncology Inc.

Dr FFPM CLVS stock SEC Form 4 insiders trading

Dr has made over 35 trades of the Clovis Oncology Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 8,374 units of CLVS stock worth 670$ on 1 November 2022.

The largest trade he's ever made was exercising 23,034 units of Clovis Oncology Inc stock on 6 April 2020 worth over 70,945$. On average, Dr trades about 3,764 units every 45 days since 2015. As of 1 November 2022 he still owns at least 116,044 units of Clovis Oncology Inc stock.

You can see the complete history of Dr Rolfe stock trades at the bottom of the page.





Dr. Lindsey Rolfe B.Sc., BSc, MB ChB, MRCP, FFPM biography

Dr. Lindsey Rolfe B.Sc., BSc, MB ChB, MRCP, FFPM is the Exec. VP of Clinical Devel. & Pharmacovigilance and Chief Medical Officer at Clovis Oncology Inc.

What is the salary of Dr FFPM?

As the Exec. VP of Clinical Devel. & Pharmacovigilance and Chief Medical Officer of Clovis Oncology Inc, the total compensation of Dr FFPM at Clovis Oncology Inc is 773,078$. There are 1 executives at Clovis Oncology Inc getting paid more, with Patrick J. Mahaffy having the highest compensation of 1,234,574$.



How old is Dr FFPM?

Dr FFPM is 53, he's been the Exec. VP of Clinical Devel. & Pharmacovigilance and Chief Medical Officer of Clovis Oncology Inc since . There are 6 older and 1 younger executives at Clovis Oncology Inc. The oldest executive at Clovis Oncology Inc is Dr. Gillian C. Ivers-Read BSc, 67, who is the Co-Founder, Exec. VP & Chief Regulatory Officer.

What's Dr FFPM's mailing address?

Lindsey's mailing address filed with the SEC is C/O ATRECA, INC., 835 INDUSTRIAL RD., SUITE 400, SAN CARLOS, CA, 94070.

Insiders trading at Clovis Oncology Inc

Over the last 13 years, insiders at Clovis Oncology Inc have traded over 37,405,827$ worth of Clovis Oncology Inc stock and bought 24,337,722 units worth 298,497,645$ . The most active insiders traders include Forest BaskettScott D SandellPeter J Barris. On average, Clovis Oncology Inc executives and independent directors trade stock every 17 days with the average trade being worth of 8,863$. The most recent stock trade was executed by Paul Edward Gross on 1 November 2022, trading 10,248 units of CLVS stock currently worth 820$.



What does Clovis Oncology Inc do?



What does Clovis Oncology Inc's logo look like?

Clovis Oncology Inc logo

Complete history of Dr Rolfe stock trades at Clovis Oncology Inc、Atreca Inc

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
1 Nov 2022 Lindsey Rolfe
See Remarks
オプション行使 8,374 1.00$ 8,374$
1 Nov 2022
116,044
1 Sep 2022 Lindsey Rolfe
See Remarks
オプション行使 5,063 1.18$ 5,974$
1 Sep 2022
112,123
1 Aug 2022 Lindsey Rolfe
See Remarks
オプション行使 8,374 1.51$ 12,645$
1 Aug 2022
109,451
1 Jun 2022 Lindsey Rolfe
See Remarks
オプション行使 5,062 0.67$ 3,404$
1 Jun 2022
105,666
1 May 2022 Lindsey Rolfe
See Remarks
オプション行使 8,374 2.00$ 16,748$
1 May 2022
102,952
1 Mar 2022 Lindsey Rolfe
See Remarks
オプション行使 20,938 1.95$ 40,829$
1 Mar 2022
107,067
1 Feb 2022 Lindsey Rolfe
See Remarks
オプション行使 8,375 2.09$ 17,504$
1 Feb 2022
88,982
1 Dec 2021 Lindsey Rolfe
See Remarks
オプション行使 687 2.94$ 2,020$
1 Dec 2021
82,974
1 Nov 2021 Lindsey Rolfe
See Remarks
オプション行使 8,374 4.56$ 38,185$
1 Nov 2021
84,612
1 Sep 2021 Lindsey Rolfe
See Remarks
オプション行使 688 4.92$ 3,385$
1 Sep 2021
78,469
1 Aug 2021 Lindsey Rolfe
See Remarks
オプション行使 8,374 4.83$ 40,446$
1 Aug 2021
80,098
1 Jun 2021 Lindsey Rolfe
See Remarks
オプション行使 687 5.13$ 3,524$
1 Jun 2021
73,924
1 May 2021 Lindsey Rolfe
See Remarks
オプション行使 8,374 5.94$ 49,742$
1 May 2021
75,723
1 Mar 2021 Lindsey Rolfe
See Remarks
オプション行使 1,313 6.23$ 8,180$
1 Mar 2021
69,710
1 Feb 2021 Lindsey Rolfe
See Remarks
オプション行使 22,250 8.46$ 188,235$
1 Feb 2021
78,534
21 Dec 2020 Lindsey Rolfe
See Remarks
オプション行使 3,438 5.25$ 18,032$
21 Dec 2020
60,003
15 Dec 2020 Lindsey Rolfe
See Remarks
オプション行使 17,241 3.28$ 56,550$
15 Dec 2020
70,718
3 Dec 2020 Lindsey Rolfe
See Remarks
オプション行使 1,312 5.41$ 7,098$
3 Dec 2020
53,823
3 Nov 2020 Lindsey Rolfe
See Remarks
オプション行使 3,749 5.14$ 19,270$
3 Nov 2020
54,746
21 Sep 2020 Lindsey Rolfe
See Remarks
オプション行使 3,437 7.07$ 24,300$
21 Sep 2020
52,744
3 Sep 2020 Lindsey Rolfe
See Remarks
オプション行使 1,313 5.08$ 6,670$
3 Sep 2020
49,636
3 Aug 2020 Lindsey Rolfe
See Remarks
オプション行使 3,749 6.14$ 23,019$
3 Aug 2020
50,521
22 Jun 2020 Lindsey Rolfe
See Remarks
オプション行使 3,438 7.29$ 25,063$
22 Jun 2020
48,500
3 Jun 2020 Lindsey Rolfe
See Remarks
オプション行使 1,312 6.68$ 8,764$
3 Jun 2020
45,418
5 May 2020 Lindsey Rolfe
See Remarks
オプション行使 3,749 7.71$ 28,905$
5 May 2020
46,107
6 Apr 2020 Lindsey Rolfe
See Remarks
オプション行使 23,034 3.08$ 70,945$
6 Apr 2020
59,091
20 Mar 2020 Lindsey Rolfe
See Remarks
オプション行使 3,437 4.43$ 15,226$
20 Mar 2020
37,785
3 Mar 2020 Lindsey Rolfe
See Remarks
オプション行使 1,313 7.42$ 9,742$
3 Mar 2020
34,708
4 Feb 2020 Lindsey Rolfe
See Remarks
オプション行使 14,997 8.83$ 132,424$
4 Feb 2020
41,225
20 Dec 2019 Lindsey Rolfe
See Remarks
オプション行使 3,438 10.98$ 37,749$
20 Dec 2019
27,957
3 Dec 2019 Lindsey Rolfe
See Remarks
オプション行使 1,312 11.67$ 15,311$
3 Dec 2019
24,872
20 Sep 2019 Lindsey Rolfe
See Remarks
オプション行使 3,437 4.74$ 16,291$
20 Sep 2019
25,625
4 Sep 2019 Lindsey Rolfe
See Remarks
オプション行使 1,313 5.12$ 6,723$
4 Sep 2019
22,563
28 Oct 2015 Lindsey Rolfe
See Remarks
オプション行使 4,000 3.08$ 12,320$
28 Oct 2015
4,000
5 Oct 2015 Lindsey Rolfe
See Remarks
オプション行使 4,000 3.08$ 12,320$
5 Oct 2015
4,000


Clovis Oncology Inc executives and stock owners

Clovis Oncology Inc executives and other stock owners filed with the SEC include: